Drug Patents owned by Mylan

1. List of Ermeza drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9345772 MYLAN Liquid levothyroxine formulations
Feb, 2035

(11 years from now)

Drugs and Companies using LEVOTHYROXINE SODIUM ingredient

Market Authorisation Date: 29 April, 2022

Treatment: NA

Dosage: SOLUTION;ORAL

More Information on Dosage

2. List of Evoclin drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7374747 MYLAN Pharmaceutical foam
Jan, 2024

(9 months from now)

US7141237 MYLAN Pharmaceutical foam
Feb, 2024

(10 months from now)

Drugs and Companies using CLINDAMYCIN PHOSPHATE ingredient

Market Authorisation Date: 22 October, 2004

Treatment: Treatment of acne vulgaris

Dosage: AEROSOL, FOAM;TOPICAL

How can I launch a generic of EVOCLIN before it's patent expiration?
More Information on Dosage

EVOCLIN family patents

8

United States

3

Australia

2

Israel

2

Argentina

2

Japan

EA

2

EA

2

Spain

2

Taiwan, Province of China

2

European Union

1

Brazil

YU

1

Yugoslavia

1

Mexico

1

Canada

1

Norway

1

New Zealand

3. List of Olux E drug patents

OLUX E's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8962000 MYLAN Microemulsion and sub-micron emulsion process and compositions
Aug, 2025

(2 years from now)

US8460641 MYLAN Microemulsion process and composition
Nov, 2028

(5 years from now)

Drugs and Companies using CLOBETASOL PROPIONATE ingredient

Market Authorisation Date: 12 January, 2007

Treatment: Treatment of corticosteroid-responsive dermatoses

Dosage: AEROSOL, FOAM;TOPICAL

How can I launch a generic of OLUX E before it's patent expiration?
More Information on Dosage

OLUX E family patents

6

United States

2

Canada

2

Australia

2

European Union

1

Israel

1

Hong Kong

1

Russia

1

Brazil

1

Japan

1

Argentina

1

South Africa

1

Spain

1

Korea, Republic of

1

Poland

1

Taiwan, Province of China

1

China

4. List of Vusion drug patents

VUSION Litigations
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8147852 MYLAN Modified azole compounds as antifungal and antibacterial agents
Mar, 2028

(5 years from now)

Drugs and Companies using MICONAZOLE NITRATE; PETROLATUM, WHITE; ZINC OXIDE ingredient

Market Authorisation Date: 16 February, 2006

Treatment: Use for treatment of diaper dermatitis complicated by candidiasis

Dosage: OINTMENT;TOPICAL

More Information on Dosage

VUSION family patents

5

United States

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in